BET Protein Inhibition Relieves MDSC-Mediated Immune Suppression in Chronic Lymphocytic Leukemia
Altogether, these data support BET inhibition as a useful therapeutic approach to reverse MDSC-mediated immune suppression in CLL.
Authors
- Elizabeth Schmitz (ORCID: https://orcid.org/0000-0002-9619-5193)
- Eslam Mohamed (ORCID: https://orcid.org/0000-0003-3360-118X)
- Audrey L. Smith (ORCID: https://orcid.org/0000-0001-5096-5351)
- Sydney A. Skupa
- Erin M. Drengler
- Dalia El-Gamal
Institutions
- California Northstate University (US)
- University of Nebraska Medical Center (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Hemato
- Published
- 2025-05-24
- DOI
- https://doi.org/10.3390/hemato6020014
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Cancer Society
- National Cancer Institute